Literature DB >> 22050544

Periodontal regeneration with enamel matrix derivative in reconstructive periodontal therapy: a systematic review.

Richard Koop1, Joe Merheb, Marc Quirynen.   

Abstract

BACKGROUND: Enamel matrix derivative (EMD) is commonly used in periodontal therapy. The aim of this systematic review is to give an updated answer to the question of whether the additional use of EMD in periodontal therapy is more effective compared with a control or other regenerative procedures.
METHODS: A literature search in MEDLINE (PubMed) for the use of EMD in periodontal treatment was performed up to May 2010. The use of EMD in treatment of intrabony defects, furcations, and recessions was evaluated. Only randomized controlled trials with ≥1 year of follow-up were included. The primary outcome variable for intrabony defects was the change in clinical attachment level (CAL), for furcations the change in horizontal furcation depth, and for recession complete root coverage.
RESULTS: After screening, 27 studies (20 for intrabony defects, one for furcation, and six for recession) were eligible for the review. A meta-analysis was performed for intrabony defects and recession. The treatment of intrabony defects with EMD showed a significant additional gain in CAL of 1.30 mm compared with open-flap debridement, EDTA, or placebo, but no significant difference compared with resorbable membranes was shown. The use of EMD in combination with a coronally advanced flap compared with a coronally advanced flap alone showed significantly more complete root coverage (odds ratio of 3.5), but compared with a connective tissue graft, the result was not significantly different. The use of EMD in furcations (2.6 ± 1.8 mm) gave significantly more improvement in horizontal defect depth compared with resorbable membranes (1.9 ± 1.4 mm) as shown in one study.
CONCLUSIONS: In the treatment of intrabony defects, the use of EMD is superior to control treatments but as effective as resorbable membranes. The additional use of EMD with a coronally advanced flap for recession coverage will give superior results compared with a control but is as effective as a connective tissue graft. The use of EMD in furcations will give more reduction in horizontal furcation defect depth compared with resorbable membranes.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22050544     DOI: 10.1902/jop.2011.110266

Source DB:  PubMed          Journal:  J Periodontol        ISSN: 0022-3492            Impact factor:   6.993


  32 in total

Review 1.  Enamel matrix derivative and bone grafts for periodontal regeneration of intrabony defects. A systematic review and meta-analysis.

Authors:  M Matarasso; V Iorio-Siciliano; A Blasi; L Ramaglia; G E Salvi; A Sculean
Journal:  Clin Oral Investig       Date:  2015-05-27       Impact factor: 3.573

2.  Biofunctionalization of porcine-derived collagen matrix using enamel matrix derivative and platelet-rich fibrin: influence on mature endothelial cell characteristics in vitro.

Authors:  Jung Soo Park; Andreas Max Pabst; Maximilian Ackermann; Maximilian Moergel; Junho Jung; Adrian Kasaj
Journal:  Clin Oral Investig       Date:  2017-07-11       Impact factor: 3.573

3.  Effects of enamel matrix derivative on non-surgical management of peri-implant mucositis: a double-blind randomized clinical trial.

Authors:  Atabak Kashefimehr; Reza Pourabbas; Masumeh Faramarzi; Ali Zarandi; Abouzar Moradi; Howard C Tenenbaum; Amir Azarpazhooh
Journal:  Clin Oral Investig       Date:  2016-12-30       Impact factor: 3.573

4.  Does enamel matrix derivative application improve clinical outcomes after semilunar flap surgery? A randomized clinical trial.

Authors:  Isabela Lima França-Grohmann; João Paulo Menck Sangiorgio; Manuela Rocha Bueno; Renato Corrêa Viana Casarin; Karina Gonzáles Silvério; Francisco Humberto Nociti; Márcio Zaffalon Casati; Enilson Antonio Sallum
Journal:  Clin Oral Investig       Date:  2018-06-12       Impact factor: 3.573

5.  Platelet-derived growth factor promotes periodontal regeneration in localized osseous defects: 36-month extension results from a randomized, controlled, double-masked clinical trial.

Authors:  Myron Nevins; Richard T Kao; Michael K McGuire; Pamela K McClain; James E Hinrichs; Bradley S McAllister; Michael S Reddy; Marc L Nevins; Robert J Genco; Samuel E Lynch; William V Giannobile
Journal:  J Periodontol       Date:  2012-05-21       Impact factor: 6.993

Review 6.  Does enamel matrix derivative application provide additional clinical benefits in the treatment of maxillary Miller class I and II gingival recession? A systematic review and meta-analysis.

Authors:  Jonathan Meza Mauricio; Camila Pinheiro Furquim; Willy Bustillos-Torrez; David Soto-Peñaloza; David Peñarrocha-Oltra; Belen Retamal-Valdes; Marcelo Faveri
Journal:  Clin Oral Investig       Date:  2021-01-21       Impact factor: 3.573

Review 7.  Efficacy of bisphosphonate as an adjunct to nonsurgical periodontal therapy in the management of periodontal disease: a systematic review.

Authors:  Zohaib Akram; Tariq Abduljabbar; Sergio Varela Kellesarian; Mohamed Ibrahim Abu Hassan; Fawad Javed; Fahim Vohra
Journal:  Br J Clin Pharmacol       Date:  2016-11-10       Impact factor: 4.335

8.  A novel flapless approach versus minimally invasive surgery in periodontal regeneration with enamel matrix derivative proteins: a 24-month randomized controlled clinical trial.

Authors:  Mario Aimetti; Francesco Ferrarotti; Giulia Maria Mariani; Federica Romano
Journal:  Clin Oral Investig       Date:  2016-04-05       Impact factor: 3.573

9.  Enamel matrix protein derivative and/or synthetic bone substitute for the treatment of mandibular class II buccal furcation defects. A 12-month randomized clinical trial.

Authors:  Lucas Araujo Queiroz; Mauro Pedrine Santamaria; Marcio Z Casati; Karina Silverio Ruiz; Francisco Nociti; Antonio Wilson Sallum; Enilson A Sallum
Journal:  Clin Oral Investig       Date:  2015-11-10       Impact factor: 3.573

10.  Surgical Approaches Based on Biological Objectives: GTR versus GBR Techniques.

Authors:  Gaia Pellegrini; Giorgio Pagni; Giulio Rasperini
Journal:  Int J Dent       Date:  2013-06-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.